What is the recommended treatment for a 16-month-old patient presenting with croup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Croup in a 16-Month-Old

Administer oral dexamethasone 0.15-0.6 mg/kg (maximum 10-12 mg) as a single dose immediately, regardless of severity, and add nebulized epinephrine (0.5 ml/kg of 1:1000 solution, maximum 5 ml) only if the child has moderate to severe symptoms with stridor at rest or respiratory distress. 1, 2

Initial Assessment

Evaluate the child for:

  • Stridor at rest (indicates moderate-severe disease requiring epinephrine) 1, 2
  • Respiratory distress (use of accessory muscles, increased work of breathing) 2
  • Oxygen saturation (hypoxemia <92% indicates need for admission) 1, 2
  • Ability to speak/cry normally and respiratory rate 2

The diagnosis is clinical—avoid radiographic studies unless you suspect an alternative diagnosis like bacterial tracheitis or foreign body aspiration. 1, 2

Treatment Algorithm

All Cases (Mild, Moderate, Severe)

  • Give oral dexamethasone 0.15-0.6 mg/kg (maximum 10-12 mg) immediately as a single dose 1, 2
  • This is the cornerstone of treatment and reduces inflammation regardless of severity 1, 3
  • If oral administration is not feasible, nebulized budesonide 2 mg is equally effective 1, 4

Moderate to Severe Cases (Stridor at Rest or Respiratory Distress)

  • Add nebulized epinephrine 0.5 ml/kg of 1:1000 solution (maximum 5 ml) 1, 2, 4
  • The effect lasts only 1-2 hours, so observe for at least 2 hours after the last dose to assess for rebound symptoms 1, 2, 4
  • Never discharge within 2 hours of epinephrine administration due to rebound risk 1, 2

Supportive Care

  • Administer oxygen to maintain saturation ≥94% if hypoxemic 2
  • Use antipyretics for comfort 2
  • Minimize handling to reduce oxygen requirements 2

Hospitalization Criteria

Consider admission after 3 doses of nebulized epinephrine (not the traditional 2 doses), which reduces hospitalization rates by 37% without increasing revisits. 5, 1, 2 This "3 is the new 2" approach is supported by recent American Academy of Pediatrics guidance. 5, 1

Additional admission criteria include:

  • Oxygen saturation <92% 1, 2
  • Age <18 months (this patient qualifies) 1, 2
  • Respiratory rate >70 breaths/min 1, 2
  • Persistent respiratory distress 1

Discharge Criteria

The child can be discharged home if:

  • Stridor at rest has resolved 1, 4
  • Minimal or no respiratory distress 1, 4
  • Adequate oral intake 1
  • Parents can recognize worsening symptoms and know to return 1, 2

Instruct parents to follow up with their pediatrician if symptoms worsen or don't improve within 48 hours. 2

Critical Pitfalls to Avoid

  • Do not discharge before 2 hours post-epinephrine due to rebound risk 1, 2, 4
  • Do not withhold steroids in mild cases—all croup patients benefit 1, 4
  • Do not admit after only 1-2 epinephrine doses when a third dose could be given safely in the ED with observation 5, 1
  • Do not use nebulized epinephrine in outpatient settings where immediate return is not feasible 1, 2, 4
  • Do not use antibiotics routinely—croup is viral 1
  • Do not rely on humidified air or cold air treatments—they lack evidence of benefit 1, 2, 6

Special Considerations for This 16-Month-Old

At 16 months, this child falls into a higher-risk category for admission based on age alone. 1, 2 If epinephrine is required, use a neutral head position with a roll under the shoulders to optimize airway patency in children under 2 years. 2

If symptoms fail to respond to standard treatment, consider alternative diagnoses including bacterial tracheitis, foreign body aspiration, or anatomic abnormalities. 1, 2

References

Guideline

Treatment of Croup in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Croup in Toddlers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Croup: an overview.

American family physician, 2011

Guideline

Treatment of Croup with Nebulization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current pharmacological options in the treatment of croup.

Expert opinion on pharmacotherapy, 2005

Related Questions

What is the treatment for croup (laryngotracheobronchitis)?
What is the recommended treatment for a 16-month-old patient presenting with croup?
What is the diagnosis and treatment for croup (laryngotracheobronchitis)?
What is the best initial treatment for a pediatric patient presenting with croup?
What is the treatment for a 5-year-old patient with croup?
What are the management options for a patient experiencing nausea due to bupropion (Wellbutrin) therapy, particularly when they are unable to eat in the morning with their dosage?
Is an elderly male patient with hypertension (HTN), impaired renal function (GFR of 46), type 2 diabetes mellitus (DMT2) with relatively well-controlled blood sugar (A1c 5.9), diastolic dysfunction grade 1, and vascular calcifications a good candidate for dapagliflozin?
What is parenteral hydromorphone?
Why give thiamine to patients with hypoglycemia, especially those with a history of alcohol abuse or malnutrition?
Can any of the patient's current medications, including Atenolol (beta blocker), buPROPion (bupropion) ER, Cefdinir (antibiotic), Folic Acid, Gabapentin (anticonvulsant), Lisinopril (ACE inhibitor), LORazepam (benzodiazepine), Methotrexate (immunosuppressant), Mounjaro (tirzepatide), Propranolol (beta blocker), and Testosterone Cypionate (anabolic steroid), increase the risk of Stevens-Johnson Syndrome (SJS) in a patient with a complex medical history, including hypertension, heart failure, rheumatoid arthritis, anxiety, and possible megaloblastic anemia and hypogonadism?
What's the next step for a patient with symptoms of anxiety, weight loss, paresthesias, and cognitive impairment, despite a negative 24-hour urinary free cortisol test result, and a history of treatment with fluoxetine (selective serotonin reuptake inhibitor), escitalopram (selective serotonin reuptake inhibitor), divalproex (valproate), buspirone (anxiolytic), dextroamphetamine-amphetamine (central nervous system stimulant), and Lybalvi (olanzapine and samidorphan)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.